Timber Pharmaceuticals Overview

Timber Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for TMBR.

Quarterly SG&A Expenses

$1.37M

↓ 9.4% YoY

As of Jun 30, 2023

Annual SG&A Expenses (TTM)

$5.81M

↓ 2.91% YoY

Trailing 12 months ending Jun 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin